Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 13Lymphoid 3Thoracic 1Sarcoma 1

Conditions

Sarcoma 16Osteosarcoma 10Carcinosarcoma 9Neoplasm Metastasis 8Rhabdomyosarcoma 7Neuroblastoma 7Melanoma 6Lymphoma, Non-Hodgkin 6Endometrial Neoplasms 6Wilms Tumor 5Sarcoma, Ewing 5Rhabdoid Tumor 5Ovarian Neoplasms 5Lung Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Gliosarcoma 5Glioblastoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Sarcoma, Kaposi 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Ependymoma 4

Interventions

Temozolomide 45Radiotherapy 20Filgrastim 17Carmustine 15Carboplatin 15Irinotecan 13Bevacizumab 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Peripheral Blood Stem Cell Transplantation 9Erlotinib Hydrochloride 9sargramostim 8O(6)-benzylguanine 8Radiation 7Topotecan 6Thiotepa 6Radiotherapy, Intensity-Modulated 6Procarbazine 6Etoposide 6Drug Therapy 6Cyclophosphamide 6Chemotherapy, Adjuvant 6aldesleukin 5Vorinostat 5Sirolimus 5Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5Busulfan 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5temsirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Specimen Handling × Sarcoma × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡